Lianhuan Pharmaceutical (600513.SH) obtained the drug registration certificate for lactulose oral solution

Zhitongcaijing · 2d ago

Zhitong Finance App News, Lianhuan Pharmaceutical (600513.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for lactulose oral solution (200ml: 133.4g/15ml: 10g) approved and issued by the State Drug Administration. This medication is indicated for chronic or habitual constipation: regulates the physiological rhythm of the colon; hepatic encephalopathy: used to treat and prevent hepatic coma or pre-coma states.